Government wants $341K back from Tom Price for private jet use

Amy Baxter | | Health Exec | Policy & Regulations
Tom Price

Tom Price, MD

Federal investigators say former HHS Secretary Tom Price wasted $341,000 of taxpayer money for his use of chartered jets and military aircraft, The New York Times reported Friday.

Price, who resigned in September 2017, may have to pay some of that money back. Daniel R. Levinson, inspector general of the HHS, said the government should try to recoup the money, which was improperly spent.

Out of 21 trips examined by the inspector general, 20 did not comply with federal requirements after Price for travel that included chartered aircraft, military aircraft, commercial aircraft or the fleet of planes equipped for use by the president and vice president.

Read the full story below:

Health Secretary Tom Price Wasted $341,000 on Improper Travel, Inquiry Finds

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.